Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 01:44 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 319.298 million compared to TWD 293.280 million a year ago. Operating income was TWD 13.936 million compared to TWD 22.759 million a year ago. Net income was TWD 21.003 million compared to TWD 25.066 million a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.34 a year ago. Diluted earnings per share was TWD 0.25 compared to TWD 0.34 a year ago. For the half year, sales was TWD 690.088 million compared to TWD 575.205 million a year ago. Operating income was TWD 59.701 million compared to TWD 46.153 million a year ago. Net income was TWD 67.677 million compared to TWD 54.231 million a year ago. Basic earnings per share was TWD 0.88 compared to TWD 0.74 a year ago. Diluted earnings per share was TWD 0.82 compared to TWD 0.73 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
